V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006520 | 190001502 | null | null | null | null | 2016-06-26 | Enzalutamide | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100936837 |
| 190006524 | 190001504 | null | 59 | Neo-adjuvant (N) | 2016-07-18 | 2016-08-10 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 100275336 |
| 190006525 | 190001505 | null | null | null | null | 2017-05-12 | CHOP R - 21 days | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100018286 |
| 190006530 | 190001508 | null | null | null | null | 2017-10-23 | OCTREOTIDE | null | null | CISPLATIN + RT | 100393769 |
| 190006533 | 190001511 | null | null | null | null | 2019-04-05 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100315845 |
| 190006538 | 190001514 | 1.74 | 75.6 | Palliative (P) | 2017-10-01 | 2017-10-05 | DOXORUBICIN | null | null | CAPECITABINE + OXALIPLATIN | 101752016 |
| 190006543 | 190001515 | null | null | null | null | 2017-01-05 | Dox + HD Mtx (post PAM) | null | null | GEMCARBO | 101053963 |
| 190006544 | 190001516 | null | 66.9 | Curative (C) | 2019-10-31 | 2019-12-07 | EW EuroEwing 2012 Arm A VIDE | 02 | N | OST AP | 100500589 |
| 190006545 | 190001517 | null | null | null | null | 2019-07-10 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 101028292 |
| 190006551 | 190001520 | 0 | 61.9 | Palliative (P) | 2019-01-13 | 2019-02-01 | EOX | 02 | N | CISPLATIN + ETOPOSIDE | 100635198 |
| 190006561 | 190001524 | 1.56 | 82.9 | Palliative (P) | 2018-09-21 | 2018-09-21 | EURAMOS TRIAL | 02 | N | CARBOPLATIN + RT | 101340426 |
| 190006564 | 190001526 | 1.79 | 63.6 | Curative (C) | 2015-12-28 | 2016-01-05 | VIDE | 2 | N | LANREOTIDE | 100707415 |
| 190006565 | 190001527 | 1.57 | 77.4 | Palliative (P) | 2017-01-21 | 2017-01-28 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101034753 |
| 190006568 | 190001528 | null | null | null | null | 2016-07-19 | Doxorubicin 75mg/m2 | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100829591 |
| 190006573 | 190001530 | null | null | null | null | 2019-01-23 | OCTREOTIDE | null | null | CISPLATIN | 101769358 |
| 190006574 | 190001531 | 1.65 | 62.1 | Palliative (P) | 2015-05-09 | 2015-05-13 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100422079 |
| 190006577 | 190001532 | 1.64 | 16.8 | Curative (C) | 2018-06-29 | 2018-06-29 | VAI (Ifos 3g/m2) | null | Y | EW EUROEWING 2012 ARM A VIDE | 100277493 |
| 190006578 | 190001533 | 1.78 | 61.9 | Adjuvant (A) | 2017-09-09 | 2017-09-09 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CISPLATIN + RT | 101314555 |
| 190006579 | 190001534 | 0 | 17.4 | Adjuvant (A) | 2016-09-27 | 2016-09-27 | STS Non-Rhabdo EpSSG 2005 IE | Y | N | BLEOMYCIN + CISPLATIN + VINCRISTINE | 100735742 |
| 190006584 | 190001537 | 1.65 | 77.4 | Neo-adjuvant (N) | 2018-11-08 | 2018-11-22 | Carboplatin + Etoposide IV 3 day | null | N | CARBOPLATIN + ETOPOSIDE | 100741993 |
| 190006589 | 190001539 | 1.51 | 79.9 | Neo-adjuvant (N) | 2019-03-12 | 2019-03-21 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101463706 |
| 190006593 | 190001542 | 1.7 | 69.1 | Curative (C) | 2019-12-25 | 2019-12-29 | CARBOPLATIN + PACLITAXEL | 02 | Y | CARBOPLATIN + PACLITAXEL | 101561777 |
| 190006595 | 190001544 | null | null | null | null | 2019-02-15 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101300360 |
| 190006600 | 190001545 | 1.8 | 84.2 | Curative (C) | 2017-02-02 | 2017-02-02 | FEC 100 + DOCETAXEL | null | Y | CARBOPLATIN | 101507178 |
| 190006602 | 190001547 | 1.71 | 63.7 | Palliative (P) | 2018-11-13 | 2018-11-20 | Dox + HD Mtx (post PAM) | 02 | N | LANREOTIDE | 101284176 |
| 190006612 | 190001550 | null | null | null | null | 2017-02-10 | CISPLATIN + ETOPOSIDE | null | null | CAPECITABINE + OXALIPLATIN | 100644721 |
| 190006617 | 190001551 | 1.57 | 65 | Curative (C) | 2012-09-02 | 2017-01-10 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | DOCETAXEL | 100764044 |
| 190006620 | 190001552 | 1.61 | 66 | Palliative (P) | 2018-01-27 | 2018-02-20 | Carboplatin + Etoposide IV 3 day | 02 | null | CARBOPLATIN + ETOPOSIDE | 100026419 |
| 190006625 | 190001553 | null | null | null | null | 2017-02-01 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100637132 |
| 190006627 | 190001554 | 0 | 54 | Neo-adjuvant (N) | null | 2018-07-12 | Carboplatin + Etoposide IV 3 day | null | null | CARBOPLATIN + ETOPOSIDE | 101473705 |
| 190006638 | 190001557 | 1.94 | 12.5 | null | 2018-09-17 | 2018-09-17 | CARBOPLATIN + RT | 02 | null | GEMCITABINE | 101198882 |
| 190006643 | 190001559 | null | null | null | null | 2018-01-03 | Carboplatin 21day + Paclitaxel 7day | null | null | CARBOPLATIN + PACLITAXEL | 101429048 |
| 190006648 | 190001561 | 1.72 | 104.3 | Palliative (P) | null | 2018-04-01 | VIDE | null | null | CAPECITABINE + OXALIPLATIN | 101620910 |
| 190006656 | 190001564 | 1.78 | 62 | Neo-adjuvant (N) | 2017-02-21 | 2017-02-21 | EURAMOS TRIAL | 02 | N | CARBOPLATIN | 101323844 |
| 190006657 | 190001565 | 1.67 | 79.3 | Palliative (P) | 2017-04-02 | 2017-04-02 | Carboplatin + Paclitaxel (weekly) | 2 | N | CARBOPLATIN + PACLITAXEL | 100826630 |
| 190006661 | 190001566 | 1.85 | 72 | Curative (C) | 2018-12-08 | 2018-12-16 | LANREOTIDE | 02 | Y | LANREOTIDE | 100283519 |
| 190006666 | 190001569 | 1.68 | 85 | Adjuvant (A) | 2020-01-09 | 2020-01-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101245603 |
| 190006680 | 190001574 | null | null | null | null | 2016-05-13 | Sunitinib | null | null | CAPECITABINE + OXALIPLATIN | 100071578 |
| 190006682 | 190001575 | 1.67 | 61.8 | Adjuvant (A) | 2018-11-23 | 2018-11-30 | EW EuroEwing 2012 Arm A VAI | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 101680903 |
| 190006694 | 190001580 | 1.75 | 56.7 | Curative (C) | 2018-06-07 | 2018-06-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101801435 |
| 190006698 | 190001582 | null | null | null | null | 2016-10-27 | Capecitabine | null | null | TRIAL UNSPECIFIED | 101472692 |
| 190006705 | 190001585 | 1.57 | 75 | Palliative (P) | 2016-07-31 | 2016-08-06 | Doxorubicin + Ifosfamide | 02 | N | FEC | 100636376 |
| 190006715 | 190001590 | 1.75 | 78.7 | Neo-adjuvant (N) | 2016-08-04 | 2016-08-19 | Cisplatin + Radiotherapy + CISPLATIN | 02 | N | CISPLATIN | 100865928 |
| 190006716 | 190001591 | 1.82 | 66 | Neo-adjuvant (N) | 2018-09-02 | 2018-09-27 | Cisplatin | 02 | N | CISPLATIN | 100702160 |
| 190006718 | 190001592 | 0 | 57 | Adjuvant (A) | 2019-02-16 | 2019-03-28 | Carboplatin + Paclitaxel (weekly) | 02 | Y | CARBOPLATIN + PACLITAXEL | 100296684 |
| 190006719 | 190001593 | 1.65 | 58.8 | Curative (C) | 2019-04-15 | 2019-04-19 | Oxaliplatin + Modified de Gramont | 01 | N | FEC + DOCETAXEL | 100360574 |
| 190006720 | 190001594 | null | null | null | null | 2016-10-18 | CARBOPLATIN + RT | null | null | OXALIPLATIN + MDG | 100516810 |
| 190006721 | 190001595 | 0 | 57.1 | Palliative (P) | 2019-09-28 | 2019-09-28 | Doxorubicin 75mg/m2 | N | N | LANREOTIDE | 101788215 |
| 190006723 | 190001596 | null | null | null | null | 2017-10-04 | ECX | null | null | EOX | 100193860 |
| 190006724 | 190001597 | 1.85 | 65.4 | Curative (C) | 2018-04-16 | 2018-04-20 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100999814 |